Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade B

Journal of Human Virology

Volumn 4, Issue 2, 2001, Pages 55-61

  Xu, W ^a   Smith Franklin, B A ^a   Li, P L ^a   Wood, C ^a   He, J ^a   Du, Q ^a   Bhat, G J ^a   Kankasa, C ^a   Katinger, H ^a   Cavacini, L A ^a   Posner, M R ^a   Burton, D R ^a   Chou, T C ^a   Ruprecht, R M ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

HIV 1 clade C; Human neutralizing monoclonal antibodies; Neutralization; Passive immunization

Indexed keywords

HUMAN MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2F5; MONOCLONAL ANTIBODY 2G12; MONOCLONAL ANTIBODY 4E10; MONOCLONAL ANTIBODY B12; UNCLASSIFIED DRUG;

ARTICLE; DISEASE TRANSMISSION; DRUG POTENTIATION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; MACACA; MONONUCLEAR CELL; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SIMIAN VIRUS; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY REACTIONS; DRUG SYNERGISM; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; NEUTRALIZATION TESTS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMIAE; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0034971817     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Prevention of mother-to-child HIV transmission in resource-poor countries: Translating research into policy and practice
2. Human immunodeficiency viruses in the developing world
3. Humoral immunity to HIV, SIV, and SHIV
4. HIV-1 neutralizing antibodies: How full is the bottle?
5. Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies
6. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
7. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
8. Advances and research directions in the prevention of mother-to-child HIV-1 transmission
9. Prevention and treatment of perinatal HIV-1 infection in the developing world
10. Effect of breast-feeding and formula feeding on transmission of HIV-1. A randomized clinical trial
11. Preventing vertical transmission of HIV infection
12. The PETRA study: Early and late efficacy of three short AZT/3TC combination regimens to prevent mother to child transmission of HIV-1: The PETRA trial
13. Generation of human monoclonal antibodies against HIV-1 proteins: Electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization
14. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody
15. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzymes inhibitors
16. Molecular cloning anal phylogenetic analysis of human immunodeficiency virus type 1 subtype C: A set of 23 full-length clones from Botswana
17. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1
18. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
19. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG
20. Intravenous immune globulin for the prevention of bacterial infection in children with symptomatic human immunodeficiency virus infection
21. Intravenous immune globulin in symptomatic pediatric human immunodeficiency virus infection
22. Phase I study of a human monoclonal antibody directed against the CD4 binding site of HIV type 1 glycoprotein 120
23. Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273)
24. Generation and assembly of secretory antibodies in plants
25. Serotyping HIV type 1 by antibody binding to the V3 loop: Relationship to viral genotype
26. Inter- and intraclade neutralization of human immunodeficiency virus type 1: Genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes
27. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: Lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement
28. Multivariate analysis of human immunodeficiency virus type 1 neutralization data
29. Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype
30. Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies
31. Immunoreactivity of intact virions of human immunodeficiency virus type 1 (HIV-1) reveals the existence of fewer HIV-1 immunotypes than genotypes